2010 News

Pregnant Woman
UC San Diego Researchers Help Create New System to Improve Safe Use of Medicines and Vaccines by Pregnant Women

The Vaccines and Medications in Pregnancy Surveillance System (VAMPSS) will collect data from women who are pregnant or have recently completed their pregnancies in order to provide information on issues that could be of concern to women and their babies.

No Evidence of Increased Risk for Those Who Become Pregnant While Taking Arava

Women who inadvertently become pregnant while being treated with leflunomide (Arava) for rheumatoid arthritis are not at increased risk of causing major defects in their unborn child, according to a recent study published in the online version of the journal Arthritis & Rheumatism.

Dr. Roberts on The Power of Collaboration

Dr. Roberts is an active proponent of collaborative medicine to caring and curing kids – especially kids with cancer.

Dr. Alysson Muotri wins 2009 NIH Director’s New Innovator Award

San Diego, September 24, 2009 - One amongst thousands of up-and-coming science superstars, 35-year old Alysson Muotri, PhD, vied for the coveted 2009 NIH Director’s New Innovator Award – and won.

Dr. Robert Mak to be the new Division Chief of Nephrology

The Department is delighted to announce the recruitment of Dr. Robert Mak, MD, PhD to be the new Division Chief of Nephrology. Dr. Mak received his education from the University of Hong Kong and University of London and completed his pediatric residency and pediatric nephrology fellowship at Guy's Hospital, University of London. He has held faculty positions at University of London, University of Southern California (Children's Hospital of Los Angeles) and Stanford University.

Durden Discovers New Biomarker for Medulloblastoma Tumor Growth

PLoS One – Dr. Donald Durden, Vice Chair of Research, Department of Pediatrics, UC San Diego and Rady Children’s Hospital, is world renowned for developing the first PI-3 kinase inhibitor in humans to mitigate tumor growth. An expert on signaling pathways in pediatric cancer research, Durden has recently discovered a marker for tumor-growth in medulloblastoma: PTEN expression.

Schwimmer First to Receive AGA/GRG Young Investigator Clinical Science Award, UC San Diego

Dr. Jeffrey Schwimmer, Associate Professor of Clinical Pediatrics, Director of Weight and Wellness, and Director of the Fatty Liver Clinic at Rady Children’s Hospital-San Diego, was awarded the 2010 Young Investigator Award in Clinical Science from the Gastroenterology Research Group (GRG) and the American Gastroenterological Association (AGA).

New England Journal of Medicine publishes pharmacokinetic guided childhood absence epilepsy study by Capparelli et al.

Published in the New England Journal of Medicine, March 2010, the results of the study challenged an ongoing myth for the pharmaceutical consumer who perceives the newest drug on the market to be better than the old.

First Annual PDRC Symposium

On February 19, 2010, we will celebrate the opening of the Pediatric Diabetes Research Center (PDRC) at the University of California, San Diego School of Medicine with a one-day inaugural symposium.

Exciting New Alliance with Rady Children’s and St. Jude Children’s Research Hospital Announced

The Department of Pediatrics is pleased to announce a new alliance to improve the care of children with cancer and other catastrophic illnesses. On July 27th, 2007 we joined with Rady Children’s Hospital to welcome a new collaborator in our research and clinical care programs: St. Jude Children’s Research Hospital, one of the premier centers for pediatric cancer research and patient care in the world.

Haddad Receives $10 Million NIH Program Project Grant to lead Hypoxia Tolerance Research Study

Dr. Gabriel G. Haddad, Chair, Department of Pediatrics, UC San Diego, and Physician-in-Chief, Rady Children’s Hospital, has been awarded a $10 million Program Project Grant from the NIH (Heart, Lung and Blood Institute). A world renowned physician-scientist in pediatric pulmonary medicine, Dr. Haddad will lead a collaborative team of investigators from UCSD and the Sanford-Burnham Medical Research Institute, to study the impact of low oxygen on cells and tissue in the heart, lung, and brain.

Dr. Marty Stein, Department of Pediatrics, Featured in Supplement to Pediatrics

Dr. Marty Stein, Professor of Pediatrics in the Division of Child Development and Community Health, UC San Diego and Rady Children’s Hospital,was featured on the front cover of the Journal of Developmental and Behavioral Pediatrics which was sent to 70,000 pediatricians nationwide together with their May issue of Pediatrics.

NEURON: La Spada et al links Nna Proteins to mitochondrial dysfunction in neurodegenerative diseases

June 24th – Dr. Albert La Spada – Division Chief of Genetics in UC San Diego’s Department of Pediatrics and Cellular and Molecular Medicine, recently identified Nna proteins as key players in the dramatic loss of neurons in mice and fly models, a discovery that could help illuminate the role of mitochondrial dysfunction in human neurodegenerative disorders, such as Parkinson’s disease.

Tremoulet Named a Harold Amos Scholar

Adriana Tremoulet, MD, assistant adjunct professor in the Department of Pediatrics, has been selected as a 2010–2014 Harold Amos Medical Faculty Development Program Scholar. Among thousands nationwide, 11 Harold Amos scholars were chosen this year based on their academic achievement, their commitment to academic research careers and their potential to achieve senior rank in academic medicine.

Durden & Castellino Discover New Biomarker for Medulloblastoma Tumor Growth

In an investigative study published in May 2010 Issue of PLoS One, Dr. Donald Durden, Vice Chair of Research, Pediatrics, UC San Diego and Rady Children’s Hospital, teamed up with Dr. Craig Castellino at Emory University to report a new role for the PI-3 kinase signaling pathway in a pediatric brain tumor. Dr. Durden, who developed the first PI-3 kinase inhibitor to enter human clinical trials in cancer cells, has discovered a new marker for tumor-growth and prognosis in medulloblastoma: PTEN expression.

“Gene Makes 'Superbugs' Resistant to Drugs,” The Wall Street Journal, features Victor Nizet, MD

Some bacteria in south Asia have learned a new way to deactivate the antibiotics that usually kill them, according to a new study, raising concerns about a novel wave of drug-resistant "superbugs" that travelers could spread world-wide.The emergence of antibiotic-resistant bacteria is common, but raises concerns when the new superbugs cause disease, according to Dr. Nizet, a professor of pediatrics and pharmacy UC San Diego, who does research on bacterial infections.